Pyloobest of vitobest is a capsules supplement that contains a patented and unique formula that helps to combat gastritis and peptic ulcer produced by helicobacter pylori. It is a single product designed in capsules easy to ingest, which contains a novel ingredient developed by the lonza laboratories, called pylopass ™ that provides you with a new way of controlling the levels of helicobacter pylori. This formulation contains a strain of the swiss lonza laboratory that is a subtype of lactobacillus reuteri with a unique mechanism of action. This strain manages to reduce the amount of stomach pylori helicobacter by a coagregation mechanism. Coagregation consists of the adhesion of the strain introduced with the bacteria of helicobacter, canceling the vital function of the host bacteria. When pylopass ™ comes into contact with the helicobacter, coagregated are formed that drag the helicobacter. Finally, these coagregates are excreted and eliminated by the gastrointestinal tract. Different clinical trials have shown its effectiveness and after the first two weeks of supplementation, a significant decrease in the levels of helicobacter pylori can be seen, reducing the episodes of gastritis associated with the infection. Contrary to probiotics, pylopass ™ consists of inactive cells that can resist sudden changes in the environment. This remains alive in shipments and storage, in addition pylopass ™ does not require specific temperature control.- it is specific to the pylori helicobacter: while probiotics supply themselves from the intestinal flora of the stomach, pylopass ™ adheres specifically al helicobacter pylori in the stomach. Due to the specific nature of the intestinal flora, pylopass ™ does not adhere to any other organism of the intestinal flora, being totally harmless for them. Stability in the gastric condition against probiotics, pylopass ™ uses a mechanism that does not need to live in intestinal flora.- probiotics can be beneficial: because they can replace harmful bacteria in the intestinal tract. However, it is not quite true that the probiotic strain can survive for a long time in an acidic environment as occurs in the stomach. This is not a problem for pylopass ™ since coagregation only depends on the union between the surface of the pyloopass ™ and the helicobacter pylori.- high tolerance: other methods to reduce the amount of helicobacter pylori can generally have side effects such as diarrhea, or change in the taste of food. On the contrary, no side effect related to pylopass ™ is known both on ingestion and administration.- does not increase antibiotics resistance: pyloopass ™ ingestion does not increase antibiotic resistance, studies demonstrate by contrary to the number of antibiotic strains against helicobacter pylori increase globally, increasing the risk of resistance from the organism to antibiotics. In asia, it is estimated that there are 37% of cases of resistance to metronidazole and 65% in africa. Pylopass ™ offers an alternative that does not contribute to increasing antibiotic resistance by reducing the amount of pylori helicobacter. Effectively.ingredientspylopass ™ (lactobacillus reuteri), load agent: maltodextrin, emulgent: magnesium stearate, antiaglomerant: silicon dioxide, wrapping: vegetable jelly vcaps®. Employment modem as dietary supplement for healthy adults, take 1 dose of 1 dose of 1 dose of 1 capsule, 1 or 2 times a day, before meals. 60 capsules.












Reviews
There are no reviews yet.